Trell is the as-executed evidence layer for GMP. You answer to the FDA for data produced on floors you don't run. The record that proves what happened during a batch almost always exists, but it's scattered across systems, sites, spreadsheets, and PDFs, and someone senior has to rebuild it by hand before anyone can release, transfer, file, or defend it. That manual reconstruction is the sponsor-CDMO evidence gap, and it quietly slows every release, APR, CPV review, comparability package, and inspection response in our industry. Trell closes it. It reads the scattered, as-executed records you and your CDMOs already produce, batch records, CoAs, and stability data, paper and PDF included, links every value back to its source, and a qualified reviewer confirms each one before it informs a decision. Read-only, writes nothing back, not a system of record. Your MES, QMS, and LIMS stay authoritative; your qualified reviewer makes every call. From there, the same source-linked record drives APR, CPV, comparability, and inspection readiness, across the sponsor-CDMO boundary that no other system reads end to end. Built by operators who carried these obligations at scale, on both sides of the sponsor-CDMO relationship.
| Website | https://trellsystems.com |
| Employees | 2 (1 on RocketReach) |
| Industry | Biotechnology Research |
Looking for a particular Trell employee's phone or email?
Arun Patel is the Founder and Director of Trell.
1 people are employed at Trell.
Trell is based in Boston, Massachusetts.